We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
-17.12%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$10.3B
AUM Growth
-$5.42B
(-34%)
Cap. Flow
-$3.01B
Cap. Flow
% of AUM
-29.19%
Top 10 Holdings %
Top 10 Hldgs %
54.96%
Holding
62
New
4
Increased
17
Reduced
26
Closed
12
Avg Time Held Equity + Options
9.3
quarters
Top 10 Avg Time Held Equity + Options
4.5
quarters
Top 20 Avg Time Held Equity + Options
7.3
quarters
Avg Time Held Equity only
9.6
quarters
Top 10 Avg Time Held Equity only
4.5
quarters
Top 20 Avg Time Held Equity only
7.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$363M |
| 2 |
DXC Technology
DXC
|
+$306M |
| 3 |
SHPG
Shire pic
SHPG
|
+$285M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 5 |
CVS Health
CVS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$817M |
| 2 |
AET
Aetna Inc
AET
|
+$732M |
| 3 |
Newell Brands
NWL
|
+$394M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$242M |
| 5 |
AGN
Allergan plc
AGN
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.29% |
| 2 | Materials | 13% |
| 3 | Technology | 8.91% |
| 4 | Industrials | 8.58% |
| 5 | Communication Services | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $794M | 7.69% |
4,563,127
+1,631,146
| +56% | +$285M |
2017 Q1
7 quarters
|
|
2
FMC
FMC
$1.29B
| $659M | 6.38% |
10,276,521
+445,070
| +5% | +$31.2M |
2015 Q1
15 quarters
|
|
3
IQVIA
IQV
$42.9B
| $623M | 6.03% |
5,362,932
+65,955
| +1% | +$7.99M |
2016 Q2
10 quarters
|
|
4
HCA Healthcare
HCA
$99.8B
| $610M | 5.9% |
4,898,569
+563,467
| +13% | +$75.6M |
2013 Q2
22 quarters
|
|
|
5
CVS Health
CVS
$112B
| $556M | 5.39% |
8,489,991
+1,875,037
| +28% | +$140M |
2017 Q3
5 quarters
|
|
|
6
Cigna
CI
$74.7B
| $516M | 5% |
2,718,586
+1,738,013
| +177% | +$363M |
2013 Q2
22 quarters
|
|
7
McKesson
MCK
$112B
| $499M | 4.84% |
4,520,886
-346,705
| -7% | -$43.2M |
2016 Q4
8 quarters
|
|
|
8
DXC Technology
DXC
$2.04B
| $490M | 4.74% |
9,213,636
+4,428,652
| +93% | +$306M |
2017 Q2
6 quarters
|
|
|
9
Alphabet (Google) Class A
GOOGL
$4.33T
| $466M | 4.51% |
8,921,020
+2,656,200
| +42% | +$144M |
2015 Q4
12 quarters
|
|
10
DuPont de Nemours
DD
$17.5B
| $461M | 4.46% |
3,402,090
-557,868
| -14% | -$80.1M |
2014 Q3
17 quarters
|
|
|
FDC
11
DELISTED
First Data Corporation
FDC
| $436M | 4.22% |
25,777,193
+3,771,164
| +17% | +$73.5M |
2016 Q2
10 quarters
|
|
12
DELISTED
Hologic
HOLX
| $407M | 3.95% |
9,914,043
+1,578,935
| +19% | +$64.8M |
2018 Q2
2 quarters
|
|
13
Tenet Healthcare
THC
$21.5B
| $307M | 2.97% |
17,895,314
| – | – |
2013 Q2
22 quarters
|
|
|
14
Thermo Fisher Scientific
TMO
$245B
| $263M | 2.55% |
1,176,841
-1,033,101
| -47% | -$242M |
2013 Q2
22 quarters
|
|
15
Elevance Health
ELV
$92.2B
| $229M | 2.22% |
872,433
-414,516
| -32% | -$114M |
2014 Q1
19 quarters
|
|
16
Universal Health Services
UHS
$10.6B
| $229M | 2.22% |
1,962,547
-829,021
| -30% | -$104M |
2016 Q3
9 quarters
|
|
17
eBay
EBAY
$51.8B
| $202M | 1.96% |
7,192,991
-4,384,445
| -38% | -$129M |
2016 Q4
8 quarters
|
|
18
Williams Companies
WMB
$91.2B
| $194M | 1.88% |
8,813,133
+254,818
| +3% | +$6.37M |
2016 Q2
10 quarters
|
|
19
DELISTED
Paramount Global Class B
PARA
| $179M | 1.73% |
4,085,751
-179,161
| -4% | -$9.52M |
2013 Q2
22 quarters
|
|
20
nVent Electric
NVT
$26.1B
| $150M | 1.45% |
6,657,097
+500,000
| +8% | +$12.1M |
2018 Q2
2 quarters
|
|
|
MTOR
21
DELISTED
MERITOR, Inc.
MTOR
| $140M | 1.36% |
8,299,201
-94,807
| -1% | -$1.62M |
2013 Q2
22 quarters
|
|
22
Microsoft
MSFT
$4.04T
| $127M | 1.23% |
1,252,751
-148,390
| -11% | -$15.9M |
2018 Q2
2 quarters
|
|
23
Bausch Health
BHC
$2.2B
| $122M | 1.18% |
6,590,308
+3,060,703
| +87% | +$72.8M |
2018 Q3
1 quarter
|
|
24
Flex
FLEX
$41B
| $119M | 1.15% |
20,790,884
-2,571,861
| -11% | -$18M |
2013 Q2
22 quarters
|
|
25
Liberty Global Class A
LBTYA
$2.92B
| $109M | 1.06% |
5,112,109
-580,756
| -10% | -$14.2M |
2014 Q2
18 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Glenview Capital Management held 62 positions worth $10.3B, down 34% from $15.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Glenview Capital Management withdrew a net $3.01B in Q4 2018, closing 12 positions and reducing 26 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $817M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 46% a quarter earlier, followed by Materials and Technology.
Against the trend, Glenview Capital Management opened a new position in Baxter International worth $57.7M.
- Glenview Capital Management's largest Q4 2018 buy was Baxter International: 877,001 shares worth $57.7M.
- Glenview Capital Management added most to Cigna in Q4 2018, an estimated $363M increase.
- Glenview Capital Management's biggest Q4 2018 reduction was Thermo Fisher Scientific, cutting an estimated $242M.
- Glenview Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $817M.
- Glenview Capital Management's ten largest holdings make up 55% of its $10.3B portfolio in Q4 2018.
- Glenview Capital Management opened 4 new positions and closed 12 in Q4 2018.
- Glenview Capital Management's portfolio value fell 34% quarter-over-quarter to $10.3B.
Based on Glenview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.